A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 Years | MicrobiomeTrials
A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 Years
CompletedPHASE3INTERVENTIONAL
Trial Details
Start: 2026-06-29Est. Completion: 2026-09-04
Enrollment target: 90 participants
Locations
GSK Investigational Site, Fukuoka, Japan
GSK Investigational Site, Hokkaido, Japan
GSK Investigational Site, Hokkaido, Japan
GSK Investigational Site, Hokkaido, Japan
GSK Investigational Site, Kumamoto, Japan
GSK Investigational Site, Mie, Japan
GSK Investigational Site, Osaka, Japan
GSK Investigational Site, Saitama, Japan
GSK Investigational Site, Saitama, Japan
GSK Investigational Site, Shizuoka, Japan
Other microbiome trials you might be interested in